One hypothesis of the cycle of anhedonia (loss of interest or pleasure) in patients with depression is illustrated in this image; this hypothesis comes from a series of experiments performed on a sample of psychology students.1 The students were given the Beck Depression Inventory (BDI), and only those who displayed either high (BDI score >20) or low (<10) depressive symptomatology were included in the study.1 As well as completing a series of questionnaires, their helping behaviour was tested during the debriefing process when, in what was made to seem like an accident, a researcher dropped a pile of papers near the participant – latency to help, and the degree of help provided was used as a proxy for helping behaviour and social anhedonia.1 Higher levels of participants not helping were seen in the high depressive symptomatology group.1

There have been attempts to assess the effectiveness of newer antidepressants against the symptoms of anhedonia; one such study found that treatment over eight weeks with a melatonin receptor agonist decreased severity scores on depression scales, as well as scores on the Snaith-Hamilton Pleasure Scale that measures anhedonia.3 However, effectiveness on symptoms of anhedonia remains an unmet need in the treatment of MDD.1,2,3

MDD=major depressive disorder

file_download Download in HQ

Related content

Abstract illustration of a human head silhouette formed by layered curved structures with a ladder running through the centre description Article
Treatment-Resistant Depression (TRD) – definition, clinical manifestation, and evidence-based treatment

Major Depressive Disorder (MDD) is a highly prevalent psychiatric condition with significant individual and socio-economic burden​. Despite the broad availability of numerous effective therapeutic interventions, up to 30% of patients fail to achieve adequate symptom relief and are classified as having treatment-resistant depression (TRD). TRD represents a significant clinical challenge, affecting approximately 30% of individuals with MDD who fail to respond to at least two adequate antidepressant trials.

25.09.2025 Depression
image Image Figure showing sequential treatment strategies for improving outcomes in major depressive disorder
Sequental Treatment Optimization Scheme for Major Depressive Disorder

Sequential treatment optimization scheme for major depressive disorder generated according to international evidence.

18.09.2025 Depression
image Image Image showing factors to evaluate when antidepressant treatment response is inadequate
Identification and effective management of factors potentially confounding treatment response

Key steps for managing factors that may confound antidepressant treatment response, including dose, side effects, comorbidities, stressors, adherence, pharmacogenomics, interactions, and treatment algorithms.

18.09.2025 Depression